GSK3β is widely recognized as a downstream target of AKT 20, and previous studies have shown that inhibition of ASPH enzymatic activity leads to increased GSK3β phosphorylation, which promotes tumor cell senescence 21,22. The gene discussed is AKT1; the disease is neoplasm.